Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: Successes and barriers

Arjan Vissink; James B. Mitchell; Bruce J. Baum; Kirsten H. Limesand; Siri Beier Jensen; Philip C. Fox; Linda S. Elting; Johannes A. Langendijk; Robert P. Coppes; Mary E. Reyland

doi:10.1016/j.ijrobp.2010.06.052

Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: Successes and barriers

Arjan Vissink
, James B. Mitchell
, Bruce J. Baum
, Kirsten H. Limesand
, Siri Beier Jensen
, Philip C. Fox
, Linda S. Elting
, Johannes A. Langendijk
, Robert P. Coppes
, Mary E. Reyland

Research output: Contribution to journal › Review article › peer-review

287 Scopus citations

Abstract

The most significant long-term complication of radiotherapy in the head-and-neck region is hyposalivation and its related complaints, particularily xerostomia. This review addresses the pathophysiology underlying irradiation damage to salivary gland tissue, the consequences of radiation injury, and issues contributing to the clinical management of salivary gland hypofunction and xerostomia. These include ways to (1) prevent or minimize radiation injury of salivary gland tissue, (2) manage radiation-induced hyposalivation and xerostomia, and (3) restore the function of salivary gland tissue damaged by radiotherapy.

Original language	English (US)
Pages (from-to)	983-991
Number of pages	9
Journal	International Journal of Radiation Oncology Biology Physics
Volume	78
Issue number	4
DOIs	https://doi.org/10.1016/j.ijrobp.2010.06.052
State	Published - Nov 4 2010

Keywords

Gene transfer
Hyposalivation
Palliative care
Prevention
Radiotherapy
Stem cell therapy
Xerostomia

ASJC Scopus subject areas

Radiation
Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

Access to Document

10.1016/j.ijrobp.2010.06.052

Cite this

Vissink, A., Mitchell, J. B., Baum, B. J., Limesand, K. H., Jensen, S. B., Fox, P. C., Elting, L. S., Langendijk, J. A., Coppes, R. P., & Reyland, M. E. (2010). Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: Successes and barriers. International Journal of Radiation Oncology Biology Physics, 78(4), 983-991. https://doi.org/10.1016/j.ijrobp.2010.06.052

Vissink, A, Mitchell, JB, Baum, BJ, Limesand, KH, Jensen, SB, Fox, PC, Elting, LS, Langendijk, JA, Coppes, RP & Reyland, ME 2010, 'Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: Successes and barriers', International Journal of Radiation Oncology Biology Physics, vol. 78, no. 4, pp. 983-991. https://doi.org/10.1016/j.ijrobp.2010.06.052

@article{4baabe019a084937af9ccf52411e0217,

title = "Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: Successes and barriers",

abstract = "The most significant long-term complication of radiotherapy in the head-and-neck region is hyposalivation and its related complaints, particularily xerostomia. This review addresses the pathophysiology underlying irradiation damage to salivary gland tissue, the consequences of radiation injury, and issues contributing to the clinical management of salivary gland hypofunction and xerostomia. These include ways to (1) prevent or minimize radiation injury of salivary gland tissue, (2) manage radiation-induced hyposalivation and xerostomia, and (3) restore the function of salivary gland tissue damaged by radiotherapy.",

keywords = "Gene transfer, Hyposalivation, Palliative care, Prevention, Radiotherapy, Stem cell therapy, Xerostomia",

author = "Arjan Vissink and Mitchell, \{James B.\} and Baum, \{Bruce J.\} and Limesand, \{Kirsten H.\} and Jensen, \{Siri Beier\} and Fox, \{Philip C.\} and Elting, \{Linda S.\} and Langendijk, \{Johannes A.\} and Coppes, \{Robert P.\} and Reyland, \{Mary E.\}",

note = "Funding Information: Funding for this conference was made possible in part by Award Number R13 DE19330 from the National Institute of Dental and Craniofacial Research . The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Partial funding was also provided by the National Cancer Institute , the National Institutes of Health Office of Rare Diseases , The University of Connecticut School of Dental Medicine , Carolinas Medical Center , The Multinational Association of Supportive Care in Cancer , and the International Society of Oral Oncology . This conference was also supported by unrestricted educational grant funds from Endo Pharmaceuticals, Inc. and from EUSA Pharma , and by funds from Biovitrum and Helsinn Healthcare SA . ",

year = "2010",

month = nov,

day = "4",

doi = "10.1016/j.ijrobp.2010.06.052",

language = "English (US)",

volume = "78",

pages = "983--991",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients

T2 - Successes and barriers

AU - Vissink, Arjan

AU - Mitchell, James B.

AU - Baum, Bruce J.

AU - Limesand, Kirsten H.

AU - Jensen, Siri Beier

AU - Fox, Philip C.

AU - Elting, Linda S.

AU - Langendijk, Johannes A.

AU - Coppes, Robert P.

AU - Reyland, Mary E.

N1 - Funding Information: Funding for this conference was made possible in part by Award Number R13 DE19330 from the National Institute of Dental and Craniofacial Research . The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Partial funding was also provided by the National Cancer Institute , the National Institutes of Health Office of Rare Diseases , The University of Connecticut School of Dental Medicine , Carolinas Medical Center , The Multinational Association of Supportive Care in Cancer , and the International Society of Oral Oncology . This conference was also supported by unrestricted educational grant funds from Endo Pharmaceuticals, Inc. and from EUSA Pharma , and by funds from Biovitrum and Helsinn Healthcare SA .

PY - 2010/11/4

Y1 - 2010/11/4

N2 - The most significant long-term complication of radiotherapy in the head-and-neck region is hyposalivation and its related complaints, particularily xerostomia. This review addresses the pathophysiology underlying irradiation damage to salivary gland tissue, the consequences of radiation injury, and issues contributing to the clinical management of salivary gland hypofunction and xerostomia. These include ways to (1) prevent or minimize radiation injury of salivary gland tissue, (2) manage radiation-induced hyposalivation and xerostomia, and (3) restore the function of salivary gland tissue damaged by radiotherapy.

AB - The most significant long-term complication of radiotherapy in the head-and-neck region is hyposalivation and its related complaints, particularily xerostomia. This review addresses the pathophysiology underlying irradiation damage to salivary gland tissue, the consequences of radiation injury, and issues contributing to the clinical management of salivary gland hypofunction and xerostomia. These include ways to (1) prevent or minimize radiation injury of salivary gland tissue, (2) manage radiation-induced hyposalivation and xerostomia, and (3) restore the function of salivary gland tissue damaged by radiotherapy.

KW - Gene transfer

KW - Hyposalivation

KW - Palliative care

KW - Prevention

KW - Radiotherapy

KW - Stem cell therapy

KW - Xerostomia

UR - https://www.scopus.com/pages/publications/77958494456

UR - https://www.scopus.com/pages/publications/77958494456#tab=citedBy

U2 - 10.1016/j.ijrobp.2010.06.052

DO - 10.1016/j.ijrobp.2010.06.052

M3 - Review article

C2 - 20970030

AN - SCOPUS:77958494456

SN - 0360-3016

VL - 78

SP - 983

EP - 991

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 4

ER -

Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: Successes and barriers

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this